维普中文期刊产品整合服务
9篇 您的检索式:作者名="LIPATOV ON"
    题名 作者 年代 出处 被引量
1Antitumor activity and safety of tivozanib ( AV-951 ) in a phase II randomized discontinuation trial in patients with renal cell carcinoma 显示文摘Nosov DA Esteves B Lipatov ON 2012J Clin Oncol2012,30,14:1
2Antitumor activity and safety of tivozanib(AV-951 ) in phase Ⅱ randomized discontinuation trial in patients with renal cell carcinoma显示文摘NOSOV DA ESTEVES B LIPATOV ON 2012J Clin Oncol2012,30,14:1
3Antitumor activity and safety of tivozanib (AV-951) in a phase II randomized discontinuation trial in patients with renal cell carcinoma 显示文摘Nosov DA Esteves B Lipatov ON 2012JClin Oncol2012,30,14:1
4Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancer 显示文摘Eckardt JR Bentsion DL Lipatov ON 2009J Clin Oncol2009,27,12:1
5Phase Ⅱ study of picoplatin as second-line therapy for patients with small-cell lung cancer显示文摘Eckardt JR Bentsion DL Lipatov ON 2009J Clin Oncol2009,27,12:1
6Phase II study of pi- coplatin as secondline therapy for patients with small-cell lung cancer显示文摘Eekardt JR Bentsion DL Lipatov ON 2009J Clin Oncol2009,27,:1
7Antitumor Activity and Safety of Tivozanib(AV-951)in a Phase Ⅱ Randomized Discontinuation Trial in Patients With Renal Cell Carcinoma显示文摘Nosov DA Esteves B Lipatov ON 0,,:1
8Antitumor activity and safety of tivozanib (AV-951) in a phase II randomized discontinuation trial in patients with renal cell carcinoma显示文摘Nosov DA Esteves B Lipatov ON 2012J Clin Oncol2012,30,14:1
9Antitumor activity and safety of tivozanib ( AV-951 ) in a phase 1I randomized discontinuation trial in patients with renal cell carcinoma显示文摘Nosov DA Esteves B Lipatov ON 2012J Clin Oncol2012,30,14:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费